Clinical Trial Update: Evaluate Quality of Life in Type 2 Diabetes, Before and After Change to Insuline Glargine [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing quality of life in adults with Type 2 diabetes after switching to insulin glargine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Type 2 | Phase 4 | Status: COMPLETED